Treace Medical Concepts (TMCI) Cash from Investing Activities (2020 - 2026)

Treace Medical Concepts' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$7.8 million for Q1 2026.

• Quarterly Cash from Investing Activities fell 312.67% year-over-year to -$7.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 million (down 75.34% YoY) and the FY2025 annual result came in at $13.3 million, down 62.54% from the prior year.
• Cash from Investing Activities was -$7.8 million for Q1 2026 at Treace Medical Concepts, down from $9.7 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $22.4 million in Q2 2024 and bottomed at -$80.5 million in Q1 2023.
• A 5-year average of -$6.9 million and a median of -$1.5 million in 2022 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities sank 7012.44% — and 2024, when it jumped 315.23%.
• Treace Medical Concepts' Cash from Investing Activities stood at -$64.0 million in 2022, then soared by 107.82% to $5.0 million in 2023, then tumbled by 31.68% to $3.4 million in 2024, then surged by 182.55% to $9.7 million in 2025, then sank by 180.86% to -$7.8 million in 2026.
• Business Quant data shows TMCI's Cash from Investing Activities at -$7.8 million in Q1 2026, $9.7 million in Q4 2025, and $8.7 million in Q3 2025.